A recombinant mhcc97-1 hepatoma cell with high expression of mutant egfr and its construction
A technology for MHCC97-L and liver cancer cells, which is applied in the direction of tumor/cancer cells, genetically modified cells, cells modified by introducing foreign genetic material, etc. It can solve the problems of tumor drug resistance and affecting the effect of treatment, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0021] The full length of the EGFR (I645L) gene obtained will be recovered after double digestion with XbaI and NotI (as shown in Figure 2).
[0023]. After the restriction enzyme digestion, the plasmid and the PCR product are connected and transformed into the DH5α competent state. Single clones were picked and sequenced. get
[0029] Placed at 37°C, forced transfection in a 5% CO2 incubator for 6-8 hours. Then add 9ml containing 10% volume concentration
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com